4.3 Article

Tuberculosis research update

Journal

TROPICAL MEDICINE & INTERNATIONAL HEALTH
Volume 15, Issue 8, Pages 981-989

Publisher

WILEY
DOI: 10.1111/j.1365-3156.2010.02568.x

Keywords

tuberculosis; vaccine; drug resistance; HIV; diagnosis

Funding

  1. European and Developing Countries Trials Partnership (EDCTP)
  2. National Institutes of Health
  3. Aeras Global TB Vaccine Foundation
  4. Bill and Melinda Gates Foundation
  5. Wellcome Trust
  6. South African National Research Foundation
  7. South African Medical Research Council
  8. European Union

Ask authors/readers for more resources

Tuberculosis (TB) remains a major challenge to global public health in the 21st century. In 2007, there were an estimated 9.27 million new cases and 1.3 million deaths among HIV-negative patients with TB. The HIV-associated TB epidemic, drug-resistant disease, the need for better diagnostic assays and the limited efficacy of Bacille Calmette-Guerin vaccination are four important obstacles to further progress in global TB control. In this brief review, we provide a focused update on these four key areas of TB research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Infectious Diseases

Effect of antibiotics on the human microbiome: a systematic review

Kristien Nel Van Zyl, Siphiwe R. Matukane, Bianca L. Hamman, Andrew C. Whitelaw, Mae Newton-Foot

Summary: Antibiotic use can alter the diversity and composition of the human microbiota. This systematic review found that certain antibiotics can cause long-term dysbiosis in the microbiome. The importance of longitudinal analysis and studies in pediatric populations was highlighted.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)

Article Infectious Diseases

Tracing TB: Are there predictors for active TB disease in patients with Xpert Ultra trace results?

Wentzel Bruce Dowling, Andrew Whitelaw, Pieter Nel

Summary: This study identified positive predictors for active TB disease in patients with trace results, including extra-pulmonary TB samples, no previous TB disease, and symptoms suggestive of TB.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Article Biochemistry & Molecular Biology

Host-Directed Targeting of LincRNA-MIR99AHG Suppresses Intracellular Growth of Mycobacterium tuberculosis

Lorna Gcanga, Ousman Tamgue, Mumin Ozturk, Shandre Pillay, Raygaana Jacobs, Julius Ebua Chia, Stanley Kimbung Mbandi, Malika Davids, Keertan Dheda, Sebastian Schmeier, Tanvir Alam, Sugata Roy, Harukazu Suzuki, Frank Brombacher, Reto Guler

Summary: A newly discovered long noncoding RNA, lincRNA-MIR99AHG, has been found to play a regulatory role in immune response and macrophage function during tuberculosis (TB) infection. Knockdown of this RNA significantly reduces intracellular TB growth and pro-inflammatory cytokine production.

NUCLEIC ACID THERAPEUTICS (2022)

Review Medicine, General & Internal

Spontaneously Expelled Lippes Loop IUD After 40 Years of Use: A Case Report and Review of the Literature

Temesgen Tilahun, Asfaw Tadesse, Rut Oljira

Summary: This article reports a case of a 75-year-old postmenopausal patient who retained a Lippes loop IUD for 40 years. The case demonstrates that spontaneous expulsion of an IUD after prolonged use is possible in the absence of embedment of the IUD into the uterine wall or uterine perforation.

INTERNATIONAL MEDICAL CASE REPORTS JOURNAL (2022)

Article Infectious Diseases

Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial

Shabir A. Madhi, Gaurav Kwatra, Simone Richardson, Anthonet L. Koen, Vicky Baillie, Clare L. Cutland, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim Ebrahim Bhorat, Carmen Briner, Khatija Ahmed, Parvinder K. Aley, Sutika Bhikha, A. E. Bhorat, Aliasgar Esmail, Elizea Horne, Haajira Kaldine, Christian K. Mukendi, Vimbai Sharon Madzorera, Nelia P. Manamela, Mduduzi Masilela, S. Tandile Hermanus, Thopisang Motlou, Nonkululeko Mzindle, Suzette Oelofse, Faeezah Patel, Sarah Rhead, Lindie Rossouw, Carol Taoushanis, Samuel van Eck, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Penny L. Moore, Alane Izu

Summary: A study in Africa found that SARS-CoV-2 infection before vaccination with the AZD1222 vaccine can enhance antibody responses for up to 180 days. This has important implications for the COVID-19 vaccine rollout in Africa.

LANCET INFECTIOUS DISEASES (2023)

Article Infectious Diseases

The impact of enteral feeding and therapeutic monitoring of rifampicin with dose escalation in critically ill patients with tuberculosis

Rubeshan Perumal, Kogieleum Naidoo, Anushka Naidoo, Marothi P. Letsoalo, Aliasgar Esmail, Ivan Joubert, Paolo Denti, Lubbe Wiesner, Nesri Padayatchi, Gary Maartens, Keertan Dheda

Summary: This study investigates the pharmacokinetics of rifampicin and the impact of continuous enteral feeding on drug absorption in critically ill patients with tuberculosis. Therapeutic drug monitoring (TDM) with dose escalation is found to be an effective strategy to achieve target drug exposure in these patients.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Editorial Material Medicine, General & Internal

A revolution in the management of multidrug-resistant tuberculosis

Keertan Dheda, Christoph Lange

LANCET (2022)

Article Multidisciplinary Sciences

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages

Jinal E. Bhiman, Simone Richardson, Bronwen Lambson, Prudence Kgagudi, Nonkululeko Mzindle, Haajira Kaldine, Carol Crowther, Glenda Gray, Linda-Gail Bekker, Anthonet Koen, Lee Fairlie, Leon Fouche, Qasim Bhorat, Keertan Dheda, Michele Tameris, Mduduzi Masilela, Zaheer Hoosain, Nishanta Singh, Sherika Hanley, Moherndran Archary, Cheryl Louw, Coert Grobbelaar, Umesh Lalloo, Natasha Joseph, Gertruida Kruger, Vivek Shinde, Chijioke M. Bennett, Gregory A. Glenn, Shabir L. Madhi, Penny Moore

Summary: The Omicron variant of concern has high resistance to neutralizing antibodies induced by vaccination or infection with previous variants. After two doses of NVX-CoV2373 vaccine, 72% and 59% of samples of Omicron sub-lineages BA.1 and BA.4/BA.5 respectively showed resistance to neutralization. However, after a third dose of NVX-CoV2373, high neutralizing titers were observed, similar to those induced by three doses of an mRNA vaccine.

SCIENTIFIC REPORTS (2023)

Article Infectious Diseases

Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit

Ilhaam Abrahams, Angela Dramowski, Kedisaletse Moloto, Lizel Lloyd, Andrew Whitelaw, Adrie Bekker

Summary: This study retrospectively analyzed the clinical characteristics, treatment methods and outcomes of neonates with carbapenem-resistant Enterobacterales (CRE) infections in a neonatal unit in South Africa, as well as the adverse reactions related to colistin. The results showed that colistin was used for premature infants with lower gestational age and lower birth weight, but the mortality rate was high. In addition, the outbreak isolates were found to be blaNDM-1 prevalent strains.

SOUTHERN AFRICAN JOURNAL OF INFECTIOUS DISEASES (2023)

Article Medicine, General & Internal

Outcomes of patients undergoing lung resection for drug-resistant TB and the prognostic significance of pre-operative positron emission tomography/computed tomography (PET/CT) in predicting treatment failure

Gregory L. Calligaro, Nevadna Singh, Timothy C. Pennel, Rachelle Steyn, Anita Brink, Aliasgar Esmail, Lynelle Mottay, Suzette Oelofse, Barbara L. Mastrapa, Wisdom Basera, Kathryn Manning, Chima Ofoegbu, Anthony Linegar, Keertan Dheda

Summary: This study investigated the treatment outcomes of drug-resistant tuberculosis patients who underwent surgery, and found that surgical intervention combined with chemotherapy led to better treatment success. However, pre-operative PET-CT did not predict treatment outcomes.

ECLINICALMEDICINE (2023)

Review Infectious Diseases

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement

Jose Dominguez, Martin J. Boeree, Emmanuelle Cambau, Dumitru Chesov, Francesca Conradie, Vivian Cox, Keertan Dheda, Andrii Dudnyk, Maha R. Farhat, Sebastien Gagneux, Martin P. Grobusch, Matthias Groeschel, Lorenzo Guglielmetti, Irina Kontsevaya, Berit Lange, Frank van Leth, Christian Lienhardt, Anna M. Mandalakas, Florian P. Maurer, Matthias Merker, Paolo Miotto, Barbara Molina-Moya, Florence Morel, Stefan Niemann, Nicolas Veziris, Andrew Whitelaw, Charles R. Horsburgh Jr, Christoph Lange

Summary: Drug-resistant tuberculosis is a global concern and molecular methods provide rapid information on mutations associated with anti-tuberculosis drug resistance. This consensus document, developed by TBnet and RESIST-TB networks, establishes reporting standards for the clinical use of molecular drug susceptibility testing. The panel identified studies linking M tuberculosis mutations with treatment outcomes, and highlights the importance of implementing molecular testing for drug resistance prediction.

LANCET INFECTIOUS DISEASES (2023)

Article Biochemistry & Molecular Biology

Recent Changes in Suicide Rates, by Race and Ethnicity and Age Group - United States, 2021

Aliasgar Esmail, Philippa Randall, Suzette Oelofse, Michele Tomasicchio, Anil Pooran, Richard Meldau, Edson Makambwa, Lynelle Mottay, Shameem Jaumdally, Gregory Calligaro, Stuart Meier, Marianna de Kock, Tawanda Gumbo, Robin Mark Warren, Keertan Dheda

Summary: Two in every five patients with active tuberculosis (TB) remain undiagnosed or unreported, highlighting the need for urgent implementation of community-based active case-finding strategies. Through an open-label, randomized controlled trial in periurban informal settlements of Cape Town, South Africa, it was found that portable, battery-operated molecular diagnostic tools can shorten time-to-treatment initiation compared to conventional POC smear microscopy, potentially curtailing transmission.

NATURE MEDICINE (2023)

Article Multidisciplinary Sciences

Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa

Elize Pietersen, Kim Anderson, Helen Cox, Keertan Dheda, Aihua Bian, Bryan E. Shepherd, Timothy R. Sterling, Robin M. Warren, Yuri F. van der Heijden

Summary: This study found that incomplete treatment with certain anti-TB drugs, such as second-line injectables and para-aminosalicylic acid (PAS), was more common than with other drugs in the treatment of drug-resistant tuberculosis. The reasons for discontinuation varied, with adverse events being the main cause for discontinuation of second-line injectables and patient refusal for discontinuation of PAS.

PLOS ONE (2023)

Article Immunology

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)

Anthonet L. Koen, Alane Izu, Vicky Baillie, Gaurav Kwatra, Clare L. Cutland, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim Ebrahim Bhorat, Carmen Briner, Khatija Ahmed, Sutika Bhikha, Jinal N. Bhiman, Jeanine du Plessis, Aliasgar Esmail, Elizea Horne, Shi-Hsia Hwa, Aylin Oommen-Jose, Teresa Lambe, Matt Laubscher, Mookho Malahleha, Gabriella Benade, Shakeel McKenzie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Tonya L. Villafana, Sarah Gilbert, Andrew J. Pollard, Shabir A. Madhi

Summary: The final analysis of the COV005 study in South African adults showed that the efficacy of the AZD1222 vaccine varied against different SARS-CoV-2 variants. The vaccine had high efficacy against the wild type virus, but lower efficacy against the Beta and Delta variants. Safety was consistent with previous findings.

VACCINE (2023)

Article Public, Environmental & Occupational Health

Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study

Rebecca Milton, David Gillespie, Calie Dyer, Khadijeh Taiyari, Maria J. Carvalho, Kathryn Thomson, Kirsty Sands, Edward A. R. Portal, Kerenza Hood, Ana Ferreira, Thomas Hender, Nigel Kirby, Jordan Mathias, Maria Nieto, William J. Watkins, Delayehu Bekele, Mahlet Abayneh, Semaria Solomon, Sulagna Basu, Ranjan K. Nandy, Bijan Saha, Kenneth Iregbu, Fatima Z. Modibbo, Stella Uwaezuoke, Rabaab Zahra, Haider Shirazi, Syed U. Najeeb, Jean-Baptiste Mazarati, Aniceth Rucogoza, Lucie Gaju, Shaheen Mehtar, Andre N. H. Bulabula, Andrew C. Whitelaw, Timothy R. Walsh, Grace J. Chan

Summary: This study aimed to determine the incidence and associations with neonatal sepsis and all-cause mortality in facility-born neonates in low-income and middle-income countries (LMICs). Findings reveal a high incidence of neonatal sepsis and its significant impact on mortality rates in LMICs.

LANCET GLOBAL HEALTH (2022)

No Data Available